Obstructive Sleep Apnea and Blood Pressure Patterns

Introduction to OSA and Blood Pressure

The American Academy of Sleep Medicine guidelines recognize that patients with obstructive sleep apnea (OSA) can have normal daytime blood pressure, despite OSA being a common cause of secondary hypertension, with a strong association between the two conditions 1, 2
Not all OSA patients develop daytime hypertension, indicating that normal daytime blood pressure is possible in this population, according to the American Academy of Sleep Medicine guidelines 1, 2
Studies demonstrate that OSA patients can be stratified by blood pressure status, with clinically significant blood pressure reductions with PAP therapy occurring primarily in those with baseline hypertension, confirming the existence of normotensive OSA patients 1, 2

OSA has a more pronounced effect on nocturnal blood pressure than daytime blood pressure, with meta-analyses showing the largest blood pressure effects during sleep, according to the American Academy of Sleep Medicine 1, 2

The American Academy of Sleep Medicine provides a strong recommendation for PAP therapy in OSA patients with excessive sleepiness, regardless of blood pressure status, with a focus on symptoms rather than blood pressure reduction as the primary outcome 3
For normotensive OSA patients, treatment decisions should focus on symptoms, such as sleepiness and impaired quality of life, rather than blood pressure reduction, according to the American Academy of Sleep Medicine guidelines 1, 2
Non-sleepy normotensive patients with OSA may have a more nuanced view of treatment, as the guidelines acknowledge these patients may not perceive the same benefit-to-burden ratio compared to symptomatic or hypertensive patients, as stated by the American Academy of Sleep Medicine 1, 2

The American Academy of Sleep Medicine guidelines demonstrate that positive airway pressure therapy produces clinically significant blood pressure reductions across multiple measurements, with nocturnal blood pressure showing the largest reductions 4, 5
Daytime and 24-hour systolic and diastolic blood pressure also decrease significantly with PAP therapy, though to a lesser extent than nocturnal measurements 4, 5
Blood pressure reductions are most clinically significant in patients with baseline hypertension or resistant hypertension 4, 5

Some studies showed BiPAP was associated with decreased mean arterial pressure in acute heart failure patients, not increased pressure 6
One study found worse outcomes with BiPAP in the out-of-hospital setting, but this was confounded by differences in nitrate dosing between groups, making it impossible to attribute outcomes to BiPAP alone 7, 8, 9